CardiaLen
Minneapolis
About CardiaLen
CardiaLen develops and commercializes pain-free cardioversion therapies for atrial fibrillation. The company is developing implantable low-energy (low voltage) pain-free atrial cardioverters to help address the major unmet needs of this condition. It was founded in 2008 and headquartered in Minneapolis, Minnesota.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $34.8M
- Funding stage: M&A
- Last round: Convertible Note (Jun 2021)
- Website: cardialen.com
- Phone: 314-615-6941
Industries & Categories
Biotechnology, Life Science, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/cardialen-29220 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.